1
|
Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, Bromberg M, Criner GJ. Response to: 'Correspondence on 'Preliminary predictive criteria for COVID-19 cytokine storm'' by Tampe et al. Ann Rheum Dis 2023; 82:e72. [PMID: 33414184 DOI: 10.1136/annrheumdis-2020-219720] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Accepted: 12/24/2020] [Indexed: 11/04/2022]
Affiliation(s)
- Roberto Caricchio
- Medicine, Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| | - Marcello Gallucci
- Università degli Studi di Milano-Bicocca Facoltà di Psicologia, Milano, Lombardia, Italy
| | - Chandra Dass
- Radiology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| | - Xinyan Zhang
- Medicine, Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| | - Stefania Gallucci
- Microbiology and Immunology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| | - David Fleece
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| | - Michael Bromberg
- Medicine/Hematology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| | - Gerard J Criner
- Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA
| |
Collapse
|
3
|
Gorgojo-Galindo Ó, Martín-Fernández M, Peñarrubia-Ponce MJ, Álvarez FJ, Ortega-Loubon C, Gonzalo-Benito H, Martínez-Paz P, Miramontes-González JP, Gómez-Sánchez E, Poves-Álvarez R, Jorge-Monjas P, Tamayo E, Heredia-Rodríguez M, Tamayo-Velasco Á. Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles. J Clin Med 2021; 10:jcm10225431. [PMID: 34830714 PMCID: PMC8622763 DOI: 10.3390/jcm10225431] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Revised: 11/11/2021] [Accepted: 11/16/2021] [Indexed: 01/08/2023] Open
Abstract
Pneumonia is the main cause of hospital admission in COVID-19 patients. We aimed to perform an extensive characterization of clinical, laboratory, and cytokine profiles in order to identify poor outcomes in COVID-19 patients. Methods: A prospective and consecutive study involving 108 COVID-19 patients was conducted between March and April 2020 at Hospital Clínico Universitario de Valladolid (Spain). Plasma samples from each patient were collected after emergency room admission. Forty-five serum cytokines were measured in duplicate, and clinical data were analyzed using SPPS version 25.0. Results: A multivariate predictive model showed high hepatocyte growth factor (HGF) plasma levels as the only cytokine related to intubation or death risk at hospital admission (OR = 7.38, 95%CI—(1.28–42.4), p = 0.025). There were no comorbidities included in the model except for the ABO blood group, in which the O blood group was associated with a 14-fold lower risk of a poor outcome. Other clinical variables were also included in the predictive model. The predictive model was internally validated by the receiver operating characteristic (ROC) curve with an area under the curve (AUC) of 0.94, a sensitivity of 91.7% and a specificity of 95%. The use of a bootstrapping method confirmed these results. Conclusions: A simple, robust, and quick predictive model, based on the ABO blood group, four common laboratory values, and one specific cytokine (HGF), could be used in order to predict poor outcomes in COVID-19 patients.
Collapse
Affiliation(s)
- Óscar Gorgojo-Galindo
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Research Unit, University Clinical Hospital, 47003 Valladolid, Spain
- Department of Surgery, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
| | - Marta Martín-Fernández
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Research Unit, University Clinical Hospital, 47003 Valladolid, Spain
- Department of Medicine, Dermatology and Toxicology, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
| | | | - Francisco Javier Álvarez
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Pharmacological Big Data Laboratory, Pharmacology Department, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
| | - Christian Ortega-Loubon
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Department of Cardiovascular Surgery, Clinic Hospital of Barcelona, 08036 Barcelona, Spain
| | - Hugo Gonzalo-Benito
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Research Unit, University Clinical Hospital, 47003 Valladolid, Spain
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Institute of Health Sciences of Castile and Leon (IECSCYL), 47002 Soria, Spain
| | - Pedro Martínez-Paz
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Department of Surgery, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
| | - José Pablo Miramontes-González
- IBSAL, Pontificia University of Salamanca, 37002 Salamanca, Spain;
- Internal Medicine Department, Rio Hortega University Hospital, 47012 Valladolid, Spain
| | - Esther Gómez-Sánchez
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Department of Surgery, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Anaesthesiology and Critical Care Department, University Clinical Hospital, 47003 Valladolid, Spain
- Correspondence: ; Tel.: +34-983420000
| | - Rodrigo Poves-Álvarez
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Anaesthesiology and Critical Care Department, University Clinical Hospital, 47003 Valladolid, Spain
| | - Pablo Jorge-Monjas
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Anaesthesiology and Critical Care Department, University Clinical Hospital, 47003 Valladolid, Spain
| | - Eduardo Tamayo
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Department of Surgery, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Anaesthesiology and Critical Care Department, University Clinical Hospital, 47003 Valladolid, Spain
| | - María Heredia-Rodríguez
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Department of Surgery, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
- Anaesthesiology and Critical Care Department, University Clinical Hospital, 37007 Salamanca, Spain
| | - Álvaro Tamayo-Velasco
- BioCritic, Group for Biomedical Research in Critical Care Medicine, 47005 Valladolid, Spain; (Ó.G.-G.); (M.M.-F.); (F.J.Á.); (C.O.-L.); (H.G.-B.); (P.M.-P.); (R.P.-Á.); (P.J.-M.); (E.T.); (M.H.-R.); (Á.T.-V.)
- Centre for Biomedical Network Research on Infectious Diseases (CIBER), Carlos III Institute of Health, 28029 Madrid, Spain
- Haematology and Hemotherapy Department, University Clinical Hospital, 47003 Valladolid, Spain;
| |
Collapse
|
4
|
Böckhaus J, Plüß M, Tampe B, Gross O. [Update on: COVID-19 and the kidney - clinic]. DER NEPHROLOGE 2021; 16:314-318. [PMID: 34394758 PMCID: PMC8353940 DOI: 10.1007/s11560-021-00530-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Accepted: 07/26/2021] [Indexed: 12/15/2022]
Affiliation(s)
- Jan Böckhaus
- Klinik für Nephrologie und Rheumatologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Deutschland
| | - Marlene Plüß
- Klinik für Nephrologie und Rheumatologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Deutschland
| | - Björn Tampe
- Klinik für Nephrologie und Rheumatologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Deutschland
| | - Oliver Gross
- Klinik für Nephrologie und Rheumatologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Deutschland
| |
Collapse
|
5
|
Tampe D, Hakroush S, Bösherz MS, Franz J, Hofmann-Winkler H, Pöhlmann S, Kluge S, Moerer O, Stadelmann C, Ströbel P, Winkler MS, Tampe B. Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study. Front Med (Lausanne) 2021; 8:644715. [PMID: 34113632 PMCID: PMC8185060 DOI: 10.3389/fmed.2021.644715] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Accepted: 04/19/2021] [Indexed: 01/08/2023] Open
Abstract
Background: Acute kidney injury (AKI) is very common in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease 2019 (COVID-19) and considered as a risk factor for COVID-19 severity. SARS-CoV-2 renal tropism has been observed in COVID-19 patients, suggesting that direct viral injury of the kidneys may contribute to AKI. We examined 20 adult cases with confirmed SARS-CoV-2 infection requiring ICU supportive care in a single-center prospective observational study and investigated whether urinary markers for viral infection (SARS-CoV-2 N) and shedded cellular membrane proteins (ACE2, TMPRSS2) allow identification of patients at risk for AKI and outcome of COVID-19. Objectives: The objective of the study was to evaluate whether urinary markers for viral infection (SARS-CoV-2 N) and shedded cellular membrane proteins (ACE2, TMPRSS2) allow identification of patients at risk for AKI and outcome of COVID-19. Results: Urinary SARS-CoV-2 N measured at ICU admission identified patients at risk for AKI in COVID-19 (HR 5.9, 95% CI 1.4–26, p = 0.0095). In addition, the combination of urinary SARS-CoV-2 N and plasma albumin measurements further improved the association with AKI (HR 11.4, 95% CI 2.7–48, p = 0.0016). Finally, combining urinary SARS-CoV-2 N and plasma albumin measurements associated with the length of ICU supportive care (HR 3.3, 95% CI 1.1–9.9, p = 0.0273) and premature death (HR 7.6, 95% CI 1.3–44, p = 0.0240). In contrast, urinary ACE2 and TMPRSS2 did not correlate with AKI in COVID-19. Conclusions: In conclusion, urinary SARS-CoV-2 N levels associate with risk for AKI and correlate with COVID-19 severity.
Collapse
Affiliation(s)
- Désirée Tampe
- Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany
| | - Samy Hakroush
- Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany
| | | | - Jonas Franz
- Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.,Max Planck Institute for Experimental Medicine, Göttingen, Germany.,Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany
| | - Heike Hofmann-Winkler
- Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research Göttingen, Göttingen, Germany
| | - Stefan Pöhlmann
- Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research Göttingen, Göttingen, Germany.,Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany
| | - Stefan Kluge
- Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Onnen Moerer
- Department of Anesthesiology, Emergency and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany
| | - Christine Stadelmann
- Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany
| | - Philipp Ströbel
- Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany
| | - Martin Sebastian Winkler
- Department of Anesthesiology, Emergency and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany
| | - Björn Tampe
- Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany
| |
Collapse
|